Can an immunoassay become a standard technique in detecting oxycodone and its metabolites?

Journal of Analytical Toxicology

Volumn 29, Issue 8, 2005, Pages 825-829

  Abadie, Jude M ^a   Allison, Kim H ^a   Black, David A ^a   Garbin, James ^a   Saxon, Andrew J ^a   Bankson, Daniel D ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; OXYCODONE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ASSAY; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; METABOLITE; OPIATE ADDICTION; POPULATION; PRESCRIPTION; SAMPLE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 29144502210     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/29.8.825     Document Type: Article

References (14)

1. E.J. Cone, R.V. Fant, and J.M. Rohay. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J. Anal. Toxicol. 27: 57-67 (2003).
2. M.L. Smith, R.O. Hughes, and B. Levine. Forensic drug testing opiates, VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry. J. Anal. Toxicol. 19: 18-26 (1999).
3. E.J. Cone, R.V. Fant, and J.M. Rohay. Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions. J. Anal. Toxicol. 28: 217-225 (2004).
4. K.A. Moore, V. Ramcharitar, B. Levine, and D. Flower. Tentative identification of novel oxycodone metabolites in human urine. J. Anal. Toxicol. 27: 346-352 (2003).
5. Substance Abuse and Mental Health Services Administration, Office of Supplied Studies. Emergency department trends from the Drug Abuse Warning Network, final estimates, 1995-2002, DAWN series D-24, DHHS Publications No. (SMA) 03-3780, Rockville, MD. Published August 2003.
6. Substance Abuse and Mental Health Services Administration, Office of Supplied Studies. Emergency department trends from the Drug Abuse Warning Network, final estimates, 1995-2002, DAWN series D-25, DHHS Publications No. (SMA) 04-3875, Rockville, MD. Published January 2004.
7. R.L. Vin Seggern, C.P. Fitzgerald, L.C. Adelman, and J.U. Adeleman. Laboratory monitoring of OxyContin (oxycodone): clinical pitfalls. Headache 44: 44-47 (2004).
8. E.J. Cone, B.D. Dickerson, and J.M. Mitchell. Forensic drug testing of opiates. IV. Analytical sensitivity, specificity, and accuracy of commercial urine opiate assays. J. Anal. Toxicol. 16: 72-78 (1992).
9. M. Gossop, D. Stewart, S. Treacy, and J. Marsden. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 97(1): 39-47 (2002).
10. S. Drake, J. Ross, D. Zador, and S. Sunjic. Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug Alcohol Depend. 60: 141-150 (2000).
11. http://www.sunone.com/articles/2001-03-02a.shtml. January 2002.
12. S. Drake and D. Zador. Fatal heroin 'overdose': a review. Addition 91: 1765-1772 (1996).
13. A. Polettini, A. Groppi, and M. Montagna. The role of alcohol abuse in the etiology of heroin-related deaths. Evidence for pharmacokinetic interactions between heroin and alcohol. J. Anal. Toxicol. 23: 570-576 (1999).
14. S. Drake, S. Sunjic, D. Zador, and T. Prolov. A comparison of blood toxicology of heroin-related deaths and current herorin users in Sydney, Australia. Drug Alcohol Depend. 47: 45-53 (1997).